Legend Biotech Corporation hat die Ernennung von Gareth Kung zum Mitglied des Board of Directors bekannt gegeben. Gareth Kung übernimmt zudem den Vorsitz des Audit Committee und tritt die Nachfolge von Tomas Heyman an.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Legend Biotech Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-26-000675), on February 06, 2026, and is solely responsible for the information contained therein.